Literature DB >> 2612507

Facial dysmorphia, parathyroid and thymic dysfunction in the father of a newborn with the DiGeorge complex.

P D Maaswinkel-Mooij1, S E Papapoulos, E J Gerritsen, A H Mudde, J J Van de Kamp.   

Abstract

A boy born at full-term died after 14 days from cardiac failure. At autopsy DiGeorge complex was diagnosed. The father was found to have facial dysmorphia and hypocalcaemia. Investigations revealed no cause other than hypoparathyroidism associated with normal serum 1,25-dihydroxyvitamin D concentrations and normal renal handling of phosphate. Immunological tests, performed on two occasions with an interval of 9 months, revealed a decrease in the number of CD8+ lymphocytes, compatible with a partial thymus deficiency. The combination of facial dysmorphia with dysfunction of the thymus and the parathyroid glands can constitute a partial DiGeorge complex. The findings in this family are compared with reports of four other families with DiGeorge complex in two generations. In genetic counseling DiGeorge complex should be considered a heterogenous disorder. Screening of the parents for somatic stigmata, hypocalcaemia, disturbed cellular immunity, cardiac and chromosomal abnormalities is essential.

Entities:  

Mesh:

Year:  1989        PMID: 2612507     DOI: 10.1007/bf01958276

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  27 in total

1.  Partial DiGeorge syndrome with substantial cell-mediated immunity.

Authors:  H F Pabst; W C Wright; J LeRiche; E R Stiehm
Journal:  Am J Dis Child       Date:  1976-03

2.  Diagnostic value of intact parathyroid hormone measurement.

Authors:  A C Nieuwenhuijzen Kruseman; M Frölich; S T Walma; R M Valentijn
Journal:  Neth J Med       Date:  1987-08       Impact factor: 1.422

3.  Unmasking of hypoparathyroidism in familial partial DiGeorge syndrome by challenge with disodium edetate.

Authors:  S S Gidding; A L Minciotti; C B Langman
Journal:  N Engl J Med       Date:  1988-12-15       Impact factor: 91.245

4.  DiGeorge's syndrome in monozygotic twins. Treatment with calcitriol.

Authors:  J D Miller; B M Bowker; D E Cole; H J Guyda
Journal:  Am J Dis Child       Date:  1983-05

5.  Studies of hypoparathyroidism and pseudohypoparathyroidism.

Authors:  I G Lewin; S E Papapoulos; S Tomlinson; G N Hendy; J L O'Riordan
Journal:  Q J Med       Date:  1978-10

6.  Cooperative effects in mitogen- and antigen-induced responses of human peripheral blood lymphocyte subpopulations.

Authors:  M H van Oers; J Pinkster; W P Zeijlemaker
Journal:  Int Arch Allergy Appl Immunol       Date:  1979

7.  A deletion in chromosome 22 can cause DiGeorge syndrome.

Authors:  A de la Chapelle; R Herva; M Koivisto; P Aula
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

8.  Familial thymic aplasia with intrauterine growth retardation and fetal death: a new syndrome or a variant of DiGeorge syndrome.

Authors:  M K Shepard; S K Linman; A Cavazos
Journal:  Birth Defects Orig Artic Ser       Date:  1976

9.  Familial DiGeorge syndrome with tetralogy of Fallot and prolonged survival.

Authors:  W E Winter; J H Silverstein; D J Barrett; E Kiel
Journal:  Eur J Pediatr       Date:  1984-01       Impact factor: 3.183

10.  Analysis for 1,25-dihydroxyvitamin D in human plasma, after a liquid-chromatographic purification procedure, with a modified competitive protein-binding assay.

Authors:  M J Jongen; W J van der Vijgh; H J Willems; J C Netelenbos
Journal:  Clin Chem       Date:  1981-03       Impact factor: 8.327

View more
  3 in total

Review 1.  Phenotype of adults with the 22q11 deletion syndrome: A review.

Authors:  E Cohen; E W Chow; R Weksberg; A S Bassett
Journal:  Am J Med Genet       Date:  1999-10-08

2.  Di-George syndrome presenting with hypocalcaemia in adulthood: two case reports and a review.

Authors:  P S Kar; B Ogoe; R Poole; D Meeking
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

Review 3.  The DiGeorge anomaly.

Authors:  R Hong
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 10.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.